Healthy volunteers help check if migraine drug formulas are equal
NCT ID NCT07261371
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tested whether different versions of a CGRP receptor antagonist (a type of migraine medicine) are absorbed and processed by the body in the same way. It involved 64 healthy adults aged 18 and older who received a single dose of each formulation. The goal was to see if the formulations are bioequivalent, meaning they have the same effect in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.